Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Medical Therapy of Heart Failure with Reduced Ejection Fraction—A Call for Comparative Research

Abstract : The armamentarium of therapies for patients with heart failure and reduced ejection fraction (HFREF) has increase substantially with the introduction of Angiotensin Receptor Neprilysin Inhibitor (ARNi), sodium glucose cotransport inhibitors (SGLTis), ivabradine, and Vericinguat, bringing to seven the number of potential therapies for HFREF. In the current review we highlight available data on the different classes of medications. Renin angiotensin blockers (RAASbs) and beta blockers (BBs) were shown to have very substantial effects in patients with HFREF. These medications are generic and hence relatively inexpensive. They have a 30-year track record of relatively benign short- and long-term safety profiles and should remain the cornerstone of therapy for patients with HFREF. ARNis are effective in further reducing adverse effects and should replace RAASbs in symptomatic HFREF patients, despite their relatively high prices. The addition of SGLTis (congested patients), Ivabradine (tachycardic patients), and Vericinguat (hypertensive patients) should be considered in patients who remain symptomatic despite optimal doses of RAASbs/ARNis, MRAs, and BBs. Comparative studies examining the efficacy of these medications, and strategies and prioritizing some over others should be considered as, given their similar side effects on heart rate, blood pressure, and renal function, it is highly unlikely that all can be given to the same patient.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal.sorbonne-universite.fr/hal-03215425
Contributeur : Gestionnaire Hal-Su <>
Soumis le : lundi 3 mai 2021 - 12:30:26
Dernière modification le : mercredi 5 mai 2021 - 03:38:43

Fichier

jcm-10-01803.pdf
Publication financée par une institution

Identifiants

Citation

Gad Cotter, Beth Davison, Alexandre Mebazaa, Koji Takagi, Maria Novosadova, et al.. Medical Therapy of Heart Failure with Reduced Ejection Fraction—A Call for Comparative Research. Journal of Clinical Medicine, MDPI, 2021, 10 (9), pp.1803. ⟨10.3390/jcm10091803⟩. ⟨hal-03215425⟩

Partager

Métriques

Consultations de la notice

38

Téléchargements de fichiers

11